Works Cited

1. Quinn TC. Epidemiology of HIV infections: international and U.S. perspectives. Hopkins HIV Rep. 1998;10(3):11-12.

2. The Associated Press. Ancestry of HIV Virus Traced. Available at http://www.nbcnews.com/id/3076791/ns/health-aids/t/ancestry-hiv-virus-traced. Last accessed February 13, 2020.

3. Centers for Disease Control and Prevention. HIV-2 infection surveillance—United States, 1987–2009. MMWR. 2011;60(29):985-988.

4. Clochesy, JM, Breu C. Critical Care Nursing. 2nd ed. Philadelphia, PA: W.B. Saunders Co.; 1996.

5. Mann JM, Chin J, Piot P, Quinn T. The international epidemiology of AIDS. Sci Am. 1988;259(4):82-89.

6. Kuhar DT, Henderson DK, Struble KA, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol. 2013;34(9):875-892.

7. Kann L, McManus T, Harris WA, et al. Youth Risk Behavior Surveillance—United States, 2017. MMWR. 2018;67(SS8):1-114.

8. Joint United Nations Programme on HIV/AIDS. 2019 Global Fact Sheet. Available at https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. Last accessed February 13, 2020.

9. Bond L, Wheeler DP, Millett GA, LaPollo AB, Carson LF, Liau A. Black men who have sex with men and the association of down-low identity with HIV risk behavior. Am J Public Health. 2009;99(Suppl 1):S92-S95.

10. Centers for Disease Control and Prevention. HIV transmission through transfusion—Missouri and Colorado, 2008. MMWR. 2010;59(41):1335-1339.

11. U.S. Department of State. Next Steps for U.S. Africa Policy: A Debrief of President Bush's Trip to Africa. Available at https:// www.cgdev.org/event/next-steps-us-africa-policy-debrief-president-bushs-trip-africa?page=139. Last accessed February 13, 2020.

12. Office of U.S. Global AIDS Coordinator. About PEPFAR. Available at https://www.pepfar.gov/about/index.htm. Last accessed February 13, 2020.

13. Centers for Disease Control and Prevention. New Hope for Stopping HIV: Testing and Medical Care Save Lives. Available at https://www.cdc.gov/vitalsigns/HIVTesting. Last accessed February 13, 2020.

14. Centers for Disease Control and Prevention. HIV transmitted from a living organ donor—New York City, 2009. MMWR. 2011;60(10):297-301.

15. Pavlakis GN, Felber BK. A new step towards an HIV/AIDS vaccine. Lancet. 2018;392(10143):192-194.

16. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV. MMWR. 2003;52(RR12):1-24.

17. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003. MMWR. 2003;52(15):329-332.

18. Centers for Disease Control and Prevention. CDC-Developed Breakthrough Technology Allows Clearest Picture to Date of HIV Infections in the U.S.: A Methods Discussion. Available at https://www2c.cdc.gov/podcasts/media/pdf/HIV_Breakthrough.pdf. Last accessed February 13, 2020.

19. Centers for Disease Control and Prevention. Press Release: National HIV Prevention Conference Echoes Themes of HHS New HIV Prevention Initiative. Available at https://www.cdc.gov/media/pressrel/r030728.htm. Last accessed February 13, 2020.

20. Wagner KD, Hardin-Pierce MG, Welsh D. High-Acuity Nursing. 7th ed. Upper Saddle River, NJ: Prentice Hall; 2018.

21. Constantine N. HIV Antibody Assays. Available at http://hivinsite.ucsf.edu/InSite?page=kb-02-02-01. Last accessed February 13, 2020.

22. Czarniecki L. Advanced HIV disease in children. Nurs Clin North Am. 1996;31(1):207-219.

23. Anderson JR (ed). A Guide to the Clinical Care of Women with HIV. Rockville, MD: U.S. Department of Health and Human Services; 2005.

24. Centers for Disease Control and Prevention. Using the BED HIV-1 Capture EIA Assay to Estimate Incidence Using STARHS in the Context of Surveillance in the United States. Available at https://npin.cdc.gov/publication/cdc-hivaids-science-facts-using-bed-hiv-1-capture-eia-assay-estimate-incidence-using. Last accessed February 13, 2020.

25. Henry J. Kaiser Family Foundation. Crystal Meth Use Fuels Rise in HIV Cases Among White MSM; "Down Low" Term Should Apply To All Races, Studies Say. Available at https://khn.org/morning-breakout/dr00030788. Last accessed February 13, 2020.

26. Centers for Disease Control and Prevention. Oral Sex and HIV Risk. Available at https://www.cdc.gov/hiv/risk/oralsex.html. Last accessed February 13, 2020.

27. International AIDS Vaccine Initiative. IAVI and Partners Initiate Early Clinical Study of New Strategy to Help Prevent HIV. Available at https://www.iavi.org/newsroom/press-releases/2014/iavi-and-partners-initiate-early-clinical-study-of-new-strategy-to-help-prevent-hiv. Last accessed February 13, 2020.

28. Henry J. Kaiser Family Foundation. Women and HIV/AIDS in the United States. Available at https://www.kff.org/hivaids/fact-sheet/women-and-hivaids-in-the-united-states/. Last accessed February 13, 2020.

29. Centers for Disease Control and Prevention. Zidovudine for the prevention of HIV transmission from mother to infant. MMWR. 1994;43(16):285-287.

30. Minkoff H, Augenbraun M. Antiretroviral therapy for pregnant women. Am J Obstet Gynecol. 1997;176:478-89.

31. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Available at https://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Last accessed February 13, 2020.

32. Centers for Disease Control and Prevention. HIV and Its Transmission. Available at https://www.cdc.gov/hiv/basics/transmission.html. Last accessed February 13, 2020.

33. National Institutes of Health, National Institute of Allergy and Infectious Diseases. Reassuring Findings About Infants Exposed to Zidovudine. Available at https://aidsinfo.nih.gov/news/465/reassuring-findings-about-infants-exposed-to-zidov. Last accessed February 13, 2020.

34. Centers for Disease Control and Prevention. Surveillance of Occupationally Acquired HIV/AIDS in Healthcare Personnel, as of December 2010. Available at https://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-Acquired-HIV-AIDS.html. Last accessed February 13, 2020.

35. Occupational Safety and Health Administration. Bloodborne Pathogens: Regulation 1910.1030. Available at https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030. Last accessed February 13, 2020.

36. Selik RM, Mokotoff ED, Branson B, Owen SM, Whitmore S, Hall HI. Revised surveillance case definition for HIV infection—United States, 2014. MMWR. 2014;63(RR3):1-10.

37. Burton DR. Advancing an HIV vaccine, advancing vaccinology. Nat Rev Immunol. 2019;19(2):77-78.

38. U.S. Department of Health and Human Services. Therapeutic HIV Vaccines. Available at https://aidsinfo.nih.gov/understanding-hiv-aids/infographics/27/therapeutic-hiv-vaccines. Last accessed February 13, 2020.

39. Dray-Spira R, Persoz A, Boufassa F, et al. Employment loss following HIV infection in the era of highly active antiretroviral therapies. Eur J Public Health. 2006;16(1):89-95.

40. Papadakis MA, McPhee SJ, Rabow MW (eds). Current Medical Diagnosis and Treatment. 59th ed. New York, NY: McGraw-Hill; 2020.

41. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(RR14):1-17.

42. Office of AIDS Research Advisory Council Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf. Last accessed February 13, 2020.

43. Centers for Disease Control and Prevention. Leading Causes of Death in Females, United States. Available at https://www.cdc.gov/women/lcod/index.htm. Last accessed February 13, 2020.

44. Human Rights Campaign. HIV Organ Policy Equity (HOPE) Act. Available at https://www.hrc.org/resources/hiv-organ-policy-equity-hope-act1. Last accessed February 13, 2020.

45. Hergenrather KC, Rhodes SD, Clark G. Windows to work: exploring employment-seeking behaviors of persons with HIV/AIDS through Photovoice. AIDS Educ Prev. 2006;18(3):243-258.

46. Centers for Disease Control and Prevention. Fact Sheet: HIV/AIDS among Persons Aged 50 and Older. Available at https://www.cdc.gov/hiv/group/age/olderamericans. Last accessed February 13, 2020.

47. American Academy of Pediatrics. Policy statement: HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics. 2008;122(5):1127-1134.

48. Rashad AM, MacVane Phipps F, Haith-Cooper M. Obtaining informed consent in an Egyptian research study. Nursing Ethics. 2004;11(4):394-399.

49. Montgomery JP, Mokotoff ED, Gentry AC, et al. The extent of bisexual behaviour in HIV-infected men and implications for transmission to their female sex partners. AIDS Care. 2003;15:829-837.

50. Carrese J, Rhodes L. Western bioethics on the Navaho reservation: benefit or harm? JAMA. 1995;274:826-829.

51. Hanssen I. An intercultural nursing perspective on autonomy. Nursing Ethics. 2004;11(1):28-41.

52. Yick A, Berthold SM. Conducting research on violence in Asian American communities: methodological issues. Violence Victims. 2005;20(6):661-677.

53. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Last accessed February 13, 2020.

54. Agency for Health Care Policy and Research. Many People with AIDS Change Their Minds About End-of-Life Care as the Disease Progresses. Available at https://archive.ahrq.gov/research/apr99/ra11.htm. Last accessed February 13, 2020.

55. Abercrombie P. Women living with HIV infection. Nurs Clin N Am. 1996;31(1):97-105.

56. National Institute of Allergy and Infectious Diseases. HIV Infection in Women. Available at https://aidsinfo.nih.gov/news/82/hiv-infection-in-women. Last accessed February 13, 2020.

57. Centers for Disease Control and Prevention. HIV transmitted from a living organ donor—New York City, 2009. MMWR. 2011;60(10):297-301.

58. Bartlett JG, Cheever LW, Johnson MP, Paauw DS (eds). Guide to Primary Care of People with HIV/AIDS. Washington, DC: U.S. Department of Health and Human Services; 2004.

59. Centers for Disease Control and Prevention. Fact Sheet: HIV Among Pregnant Women, Infants, and Children. Available at https://www.cdc.gov/hiv/group/gender/pregnantwomen. Last accessed February 13, 2020.

60. U.S. Preventative Services Task Force. Screening for HIV. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/human-immunodeficiency-virus-hiv-infection-screening1. Last accessed February 13, 2020.

61. U.S. Department of Labor. Employment and Living with HIV/AIDS. Available at https://www.dol.gov/odep/topics/HIVAIDS/. Last accessed February 13, 2020.

62. Schneider E, Whitmore S, Glynn MK, Dominguez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years—United States, 2008. MMWR. 2008;57(RR10):1-8.

63. Centers for Disease Control and Prevention. Update to interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection: PrEP for injecting drug users. MMWR. 2013;62(23):463-465.

64. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR. 1994;43(RR12):1-10.

65. AIDS InfoNet. Fact Sheet Number 616: Older People and HIV. Available at http://www.aidsinfonet.org/fact_sheets/view/616. Last accessed February 13, 2020.

66. Haile B. The forgotten tenth: AIDS in the older generation. RITA Newsletter. 1998;4(3):15-16.

67. National Institute on Aging. HIV, AIDS and Older People. Available at https://www.nia.nih.gov/health/hiv-aids-and-older-people. Last accessed February 13, 2020.

68. Shelton DL. AIDS in the "golden years:" new challenges for doctors. Am Med News. 1999;42:29-30.

69. Notario-Pérez F, Ruiz-Caro R, Veiga-Ochoa MD. Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes. Drug Des Devel Ther. 2017;11:1767-1787.

70. Carey RF, Herman WA, Retta SM, Rinaldi JE, Herman BA, Athey TW. Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under the conditions of simulated use. Sex Transm Dis. 1992;19(4):230-234.

71. Giannou FK, Tsiara CG, Nikolopoulos GK, et al. Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Rev Pharmacoecon Outcomes Res. 2016;16(4):489-499.

72. Hall JK. Nursing Ethics and Law. Philadelphia, PA: W.B. Saunders Company; 1996.

73. American Academy of Pediatrics Committee on Psychosocial Aspects of Child and Family Health and Committee on Adolescence. Sexuality education for children and adolescents. Pediatrics. 2016;138(2):e1-e11.

74. Rabkin JG, McElhiney M, Ferrando SJ, Van Gorp W, Lin SH. Predictors of employment of men with HIV/AIDS: a longitudinal study. Psychosom Med. 2004;66;72-78.

75. Centers for Disease Control and Prevention. Elimination of Mother-to-Child HIV Transmission (EMCT) in the United States. Available at https://www.cdc.gov/hiv/group/gender/pregnantwomen/emct.html. Last accessed February 13, 2020.

76. Fiesta J. HIV legal update: part 3. Nursing Management. 1996;27(12):11,14.

77. National Conference of State Legislatures. HIV/AIDS Facts to Consider: 1999. Denver, CO: National Conference of State Legislatures; 1999.

78. Centers for Disease Control and Prevention. HIV/AIDS Prevention Research Synthesis Project. Available at https://www.cdc.gov/hiv/dhap/prb/prs/index.html. Last accessed February 13, 2020.

79. Ahn J, Cohen SM. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl. 2008;14(11):1603-1608.

80. Centers for Disease Control and Prevention. HIV Among Women. Available at https://www.cdc.gov/hiv/group/gender/women/index.html. Last accessed February 13, 2020.

81. Centers for Disease Control and Prevention. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States, 2017 Update. Available at https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf. Last accessed February 13, 2020.

82. National Institute of Allergy and Infectious Disease. HIV Vaccine Development. Available at https://www.niaid.nih.gov/diseases-conditions/hiv-vaccine-development. Last accessed February 13, 2020.

83. Centers for Disease Control and Prevention. Trends in HIV-related risk behaviors among high school students—United States, 1991–2011. MMWR. 2012;61(29):556-560.

84. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Available at https://www.aidsinfo.nih.gov/contentfiles/lvguidelines/pediatricguidelines.pdf. Last accessed February 13, 2020.

85. Centers for Disease Control and Prevention. Syringe Disinfection for Injection Drug Users. Available at https://stacks.cdc.gov/view/cdc/31783. Last accessed February 13, 2020.

86. U.S. Department of Health and Human Services. Discrimination on the Basis of Disability. Available at https://www.hhs.gov/civil-rights/for-individuals/disability/index.html. Last accessed February 13, 2020.

87. U.S. Department of Justice, Civil Rights Division. Questions and Answers: The Americans with Disabilities Act and Persons with HIV/AIDS. Available at https://www.ada.gov/hiv/ada_q&a_aids.htm. Last accessed February 13, 2020.

88. U.S. Food and Drug Administration. Truvada for PrEP Fact Sheet: Ensuring Safe a Proper Use. Available at https://www.fda.gov/media/83586/download. Last accessed February 13, 2020.

89. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-2599.

90. MacPherson P, Munthali C, Ferguson J, et al. Service delivery interventions to improve adolescents' linkage, retention and adherence to antiretroviral therapy and HIV care. Trop Med Int Health. 2015;20(8):1015-1032.

91. U.S. Food and Drug Administration. FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic Last accessed February 13, 2020.

92. Centers for Disease Control and Prevention. HIV Testing. Available at https://www.cdc.gov/vitalsigns/hiv-testing/index.html. Last accessed February 13, 2020.

93. Centers for Disease Control and Prevention. Diagnoses of HIV Infection in the United States and Dependent Areas, 2018. Available at https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Last accessed February 13, 2020.

94. McCree DH, Oster AM, Jeffries IV WL, et al. HIV acquisition and transmission among men who have sex with men and women: what we know and how to prevent it. Prevent Med. 2017;100:132-134.

95. U.S. Department of Health and Human Services. FDA-Approved HIV Medicines. Available at https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/21/58/fda-approved-hiv-medicines. Last accessed February 13, 2020.

96. U.S. Food and Drug Administration. FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-extended-release-injectable-drug-regimen-adults-living-hiv. Last accessed February 25, 2021.

Evidence-Based Practice Recommendations Citations

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Bethesda, MD: U.S. Department of Health and Human Services; 2019. Available at https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Last accessed February 21, 2020.

2. U.S. Preventive Services Task Force. Screening for HIV infection: U.S. Preventive Services Task Force Recommendation Statement. JAMA. 2019;321(23):2326-2336. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/human-immunodeficiency-virus-hiv-infection-screening1. Last accessed February 21, 2020.


Copyright © 2020 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.